IDBI Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.19%)Nav, as on 09-12-2019

  • Previous Nav

  • Net Change on 09-12-2019

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
S&P BSE Health Care - TRI 1.81 2.42 -1.70 -4.39 -1.56 11.60

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 Unrated 1.67 1.84 3.62 2.20 2,429.66
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 Unrated -0.08 -5.18 -0.33 2.37 936.91
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 Unrated 2.05 -2.53 -0.23 2.63 392.78

Fund Holdings as on 30-November-2019

  • TREPS

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Cipla Ltd.

  • Lupin Ltd.

  • Sanofi India Ltd.

  • IPCA Laboratories Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Aurobindo Pharma Ltd.

  • Pfizer Ltd.

  • Natco Pharma Ltd.

  • Abbott India Ltd.

  • Alkem Laboratories Ltd.

  • Apollo Hospitals Enterprise Ltd.

  • Dr. Lal Path labs Ltd.

  • Syngene International Ltd.

  • Alembic Pharmaceuticals Ltd.

  • Biocon Ltd.

  • Net Receivable / Payable

  • ICICI Lombard General Insurance Company Ltd.

  • AstraZeneca Pharma India Ltd.

  • Aarti Industries Ltd.

  • Cadila Healthcare Ltd.

View More

  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

  • Insurance

  • Chemicals

  • Finance - Others

View More

About IDBI Healthcare Fund

Scheme Analysis

IDBI Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to IDBI Mutual Fund. It was launched on 28-Feb-2019 and currently has an AUM of ₹32.65 crore. IDBI Healthcare Fund is benchmarked against S&P BSE Health Care - TRI as primary index.

The NAV of IDBI Healthcare Fund ended down ₹-0.02(-0.19%)yesterday to ₹10.47.

Among its top 3 holdings the fund has exposure to TREPS, Sun Pharmaceutical Industries Ltd. and Divi's Laboratories Ltd.

The IDBI Healthcare Fund is managed by Uma Venkatraman .

Fund House Contact

5th floor, Mafatlal Centre, Nariman Point Mumbai - 400021

022-6644 2800
022-6644 2802

Fund Manager

  • Cash

  • Equity

View More